Background
Dr. Tahir Yusufaly's current research applies quantitative modeling in order to predict therapeutic responses to radionuclide therapy, specifically alpharadiopharmaceutical therapy (alpha-RPT).
Dr. Yusufaly earned his Ph.D. in physics from Rutgers University. He then worked in postdoctoral research in biochemistry and molecular biology at Michigan State University, theoretical biophysics at the University of Southern California, and medical physics at the University of California San Diego. He received his M.S. in Medical Physics from Georgia Tech University.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.